Chile (2025, preliminary)
4,095.0
USD PPP per capita
+2.3% YoY
Government share
56.5
% of total (2024)
Private share
43.5
% of total (2024)
10-year change
+123.3
% since 2015

Data

Current Health Expenditure per Capita in Chile (2025) — source data. OECD.
Year USD PPP per capita YoY Change
2025 4,095 +2.3%
2024 4,003 +13.9%
2023 3,515.5 +12.3%
2022 3,130.1 +9.9%
2021 2,848.3 +14.4%
2020 2,489.4 +4.2%
2019 2,389.4 +5.6%
2018 2,262.5 +6.7%
2017 2,119.6 +9.2%
2016 1,941.3 +5.9%
2015 1,833.6 +4.5%
2014 1,755 +5.8%
2013 1,658.1 +11.6%
2012 1,485.3 +9.6%
2011 1,355.5 +8.1%
2010 1,254.3 +3.7%
2009 1,209.2 +7.1%
2008 1,129.4 +6.5%
2007 1,060.7 +10.6%
2006 959.5 +18.4%
2005 810.7 +6.0%
2004 764.6 +9.1%
2003 700.7 +7.8%
2002 650.2 +5.6%
2001 615.6 +5.2%
2000 585.4 n/a

About this Dataset

Chile recorded 4,095.0 USD PPP per capita in current health expenditure in 2025, an OECD preliminary estimate up +92.1 from 2024's finalized figure of 4,003.0. Spending has grown in most years since 2000, when the series started at 585.4 USD PPP, with the steepest jump, +487.5, coming in 2024.

Government and compulsory insurance schemes typically fund just over half of this spending: in 2024 they covered about 56.5% of the total (2,263.2 USD PPP per capita), with voluntary insurance and household out-of-pocket payments making up the remaining 43.5% (1,739.7 USD PPP). The government share has typically run a few points higher over the past decade than in the early 2000s.

Compared with OECD peers, Chile's per-capita spending in 2023 (3,515.5 USD PPP) was roughly 61% of the unweighted 38-member OECD average of about 5,755.1 USD PPP for that year — well below the United States (13,932.6 USD PPP) but likely ahead of regional peers such as Mexico (1,520.0 USD PPP) and Colombia (1,885.8 USD PPP). The chart above shows the full 2000–2025 trend; the table below lists annual values with year-on-year changes.

Data sourced from the OECD System of Health Accounts (SHA) via SDMX REST API, filtered to Chile (CHL), total current health expenditure across all financing schemes, converted to USD at purchasing power parity. The most recent year is flagged provisional by the OECD and may be revised. The OECD average cited above is an unweighted mean across the 38 current OECD member countries, computed from the same dataset and vintage.

Frequently Asked Questions

This indicator tracks total current spending on health care per person in Chile, converted to USD at purchasing power parity (PPP) so levels are comparable across countries. It covers spending by government schemes, private insurance, and out-of-pocket payments, published annually by the OECD under its System of Health Accounts (SHA). The most recent reading is 4,095.0 USD PPP in 2025 (preliminary).

The series runs through 2025, though that year is flagged as a preliminary OECD estimate. The last fully finalized observation is 2024, at 4,003.0 USD PPP per capita. Figures are typically revised as national health accounts are finalized, so the 2025 value may shift in future OECD updates.

In 2023 — the most recent year with complete data across OECD members — Chile recorded 3,515.5 USD PPP per capita, roughly 61% of the unweighted 38-member OECD average of about 5,755.1 USD PPP for the same year. Chile is typically among the lower-to-mid per-capita spenders within the OECD, well below the United States (13,932.6 USD PPP in 2023) but ahead of several regional and lower-income OECD peers such as Mexico (1,520.0 USD PPP) and Colombia (1,885.8 USD PPP).

In 2024, government and compulsory schemes covered an estimated 2,263.2 USD PPP per capita (about 56.5% of the total), while voluntary insurance and household out-of-pocket payments accounted for roughly 1,739.7 USD PPP (about 43.5%). The government share has typically run higher in recent years than in the early 2000s, when it covered close to 53% of total spending.

Per-capita spending has risen in most years since 2000, from 585.4 USD PPP that year to 4,095.0 USD PPP in 2025 — an increase of roughly 123% just since 2015. The largest single-year jump came in 2024, at +487.5 USD PPP, with 2021 and 2022 also seeing sizable increases likely tied to pandemic-related health outlays and their aftermath.